The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Nov 2016 07:00

RNS Number : 9727P
Ideagen PLC
24 November 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

IDEAGEN PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify): Stock Lending. Pl

 

x

3. Full name of person(s) subject to thenotification obligation: iii

LIONTRUST INVESTMENT PARTNERS LLP

4. Full name of shareholder(s) (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

22/11/2016

6. Date on which issuer notified:

23/11/2016

7. Threshold(s) that is/are crossed orreached: vi, vii

11 %

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00B0CM0C50

 19,875,607

19,875,607

 20,144,413

20,144,413

N/A

11.09%

N/A

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

Nominal

Delta

N/A

N/A

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

20,144,413

11.09%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

13. Additional information:

 

14. Contact name:

Milly Porter

15. Contact telephone number:

020 7412 1702

   

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLAKNDNQBDDFDB
Date   Source Headline
9th Jun 202212:15 pmGNWForm 8.3 - [IDEAGEN PLC 08 06 2022] - CGWL
9th Jun 202211:39 amRNSForm 8.5 (EPT/RI)
9th Jun 202211:28 amRNSForm 8.3 - Ideagen Plc Amended
9th Jun 202210:55 amGNWForm 8.3 - Ideagen PLC
9th Jun 202210:54 amRNSForm 8.3 - IDEAGEN PLC
9th Jun 20229:56 amGNWForm 8.3 - Ideagen PLC
8th Jun 20223:31 pmRNSForm 8.3 - Ideagen Plc
8th Jun 20223:30 pmRNSForm 8.3 - IDEA LN
8th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
8th Jun 20223:17 pmBUSForm 8.3 - Ideagen plc
8th Jun 20223:00 pmBUSForm 8.3 - Ideagen plc
8th Jun 20222:29 pmRNSForm 8.3 - Ideagen Plc
8th Jun 20222:13 pmRNSForm 8.3 - Ideagen plc
8th Jun 20221:55 pmRNSForm 8.3 - Ideagen Plc
8th Jun 20221:16 pmRNSForm 8.3 - IDEAGEN PLC
8th Jun 202211:40 amRNSForm 8.3 - Ideagen Plc
8th Jun 202211:32 amGNWForm 8.3 - Ideagen PLC
8th Jun 202211:29 amRNSForm 8.5 (EPT/RI)
8th Jun 202210:40 amGNWForm 8.3 - [IDEAGEN PLC 07 06 2022] - CGWL
7th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
7th Jun 20223:15 pmBUSForm 8.3 - Ideagen plc
7th Jun 20223:08 pmRNSForm 8.3 - Ideagen Plc
7th Jun 20222:26 pmRNSForm 8.3 - IDEAGEN PLC
7th Jun 202212:34 pmRNSForm 8.3 - Ideagen PLC
7th Jun 202212:15 pmRNSForm 8.3 - Ideagen plc
7th Jun 202212:02 pmRNSForm 8.3 - Ideagen Plc
7th Jun 202211:57 amBUSForm 8.3 - Ideagen Plc
7th Jun 202211:21 amRNSForm 8.5 (EPT/RI)
7th Jun 20229:51 amGNWForm 8.3 - Ideagen PLC
7th Jun 20227:00 amBUSForm 8.3 - Ideagen PLC
6th Jun 20225:43 pmRNSHolding(s) in Company
6th Jun 20223:53 pmRNSForm 8.3 - Ideagen Plc
6th Jun 20221:17 pmRNSForm 8.3 - IDEAGEN PLC
6th Jun 202211:20 amRNSForm 8.3 - Ideagen plc
6th Jun 202211:11 amGNWForm 8.3 - Ideagen Plc
6th Jun 20229:05 amRNSHolding(s) in Company
6th Jun 20229:00 amBUSForm 8.3 - Ideagen plc
6th Jun 20228:52 amRNSForm 8.3 - Ideagen Plc
6th Jun 20227:00 amRNSForm 8.5 (EPT/RI)
6th Jun 20227:00 amRNSForm 8.3 - Ideagen plc
1st Jun 20224:50 pmRNSForm 8.3 - Ideagen Plc
1st Jun 20224:21 pmBUSForm 8.3 - Ideagen plc
1st Jun 20224:17 pmRNSForm 8.5 (EPT/RI)- Amendment
1st Jun 20223:57 pmRNSForm 8.3 - IDEAGEN PLC
1st Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
1st Jun 20223:04 pmRNSForm 8.3 - Ideagen PLC
1st Jun 20221:59 pmRNSForm 8.3 - Ideagen plc
1st Jun 20221:20 pmRNSForm 8.3 - Ideagen plc
1st Jun 20221:00 pmRNSTotal Voting Rights
1st Jun 202212:57 pmGNWForm 8.3 - [Ideagen plc - 31 05 2022] - (CGWL)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.